| Consuelito Ana Medrano, MD | |
|
235 N Belle Mead Rd, East Setauket, NY 11733-3456 | |
| (631) 751-3000 | |
| Not Available |
| Full Name | Consuelito Ana Medrano |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 22 Years |
| Location | 235 N Belle Mead Rd, East Setauket, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578664645 | NPI | - | NPPES |
| 5127962 | Other | NY | AETNA |
| 6759419 | Other | NY | CIGNA |
| 03613870 | Medicaid | NY | |
| 38Q672 | Other | NY | EMPIRE BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 267954 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Mary's Hospital | Waterbury, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trinity Health Of New England Provider Network Organization Inc | 0941113567 | 621 |
News Archive
Oxidative stress is a significant predictor for hip fracture in postmenopausal women, according to new research led by University of Cincinnati (UC) epidemiologists.
Increased blood sugar levels in diabetics could damage DNA and make the genome unstable, increasing the risk of certain cancers.
New research, published in The Lancet Oncology, has found that combining human papillomavirus (HPV) testing with routine liquid-based cytology (LBC) screening does not increase the detection of cervical cancer compared with LBC screening alone. The trial funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme aimed to determine whether testing for HPV in the cervix might increase the effectiveness of the cervical screening programme.
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of an exclusive worldwide license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.
› Verified 8 days ago
| Entity Name | Trinity Health Of New England Provider Network Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003882812 PECOS PAC ID: 0941113567 Enrollment ID: O20031110000651 |
News Archive
Oxidative stress is a significant predictor for hip fracture in postmenopausal women, according to new research led by University of Cincinnati (UC) epidemiologists.
Increased blood sugar levels in diabetics could damage DNA and make the genome unstable, increasing the risk of certain cancers.
New research, published in The Lancet Oncology, has found that combining human papillomavirus (HPV) testing with routine liquid-based cytology (LBC) screening does not increase the detection of cervical cancer compared with LBC screening alone. The trial funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme aimed to determine whether testing for HPV in the cervix might increase the effectiveness of the cervical screening programme.
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of an exclusive worldwide license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Consuelito Ana Medrano, MD 235 N Belle Mead Rd, East Setauket, NY 11733-3456 Ph: (631) 751-3000 | Consuelito Ana Medrano, MD 235 N Belle Mead Rd, East Setauket, NY 11733-3456 Ph: (631) 751-3000 |
News Archive
Oxidative stress is a significant predictor for hip fracture in postmenopausal women, according to new research led by University of Cincinnati (UC) epidemiologists.
Increased blood sugar levels in diabetics could damage DNA and make the genome unstable, increasing the risk of certain cancers.
New research, published in The Lancet Oncology, has found that combining human papillomavirus (HPV) testing with routine liquid-based cytology (LBC) screening does not increase the detection of cervical cancer compared with LBC screening alone. The trial funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme aimed to determine whether testing for HPV in the cervix might increase the effectiveness of the cervical screening programme.
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of an exclusive worldwide license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.
› Verified 8 days ago
Dr. William H Greene, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 205 N Belle Mead Ave, East Setauket, NY 11733 Phone: 631-444-1660 | |
Dr. Ellen Li, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3 Technology Dr, East Setauket, NY 11733 Phone: 631-444-5220 | |
Dr. Diane Klein-ritter, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 205 N Belle Mead Ave, East Setauket, NY 11733 Phone: 631-444-4630 | |
Ms. Larisa V Venezia, DO Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 46 Route 25a, Suite 6, East Setauket, NY 11733 Phone: 631-689-1444 Fax: 631-689-1448 | |
Nardeen Mickail, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 14 Technology Dr, Suite 10, East Setauket, NY 11733 Phone: 631-689-5400 Fax: 631-689-8247 | |
David M Franko, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 45 Research Way, Suite 008 & 108, East Setauket, NY 11733 Phone: 631-941-2704 Fax: 631-941-2009 | |
Christopher M Cesa, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 45 Research Way, Suite 008 & 108, East Setauket, NY 11733 Phone: 631-941-2704 Fax: 631-941-2009 |